At a glance
- Originator Nonindustrial source
- Class Analgesics; Peptides
- Mechanism of Action Opioid mu receptor agonists; Opioid mu receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Pain
Most Recent Events
- 28 Mar 2000 No-Development-Reported for Pain in USA (Unknown route)
- 03 Mar 1997 New profile
- 03 Mar 1997 Preclinical development for Pain in USA (Unknown route)